Oppenheimer & CO Inc Quest Diagnostics Inc Transaction History

Oppenheimer & CO Inc

  • $6.52 Billion
  • Q4 2024

A detailed history of Oppenheimer & CO Inc transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Oppenheimer & CO Inc holds 44,523 shares of DGX stock, worth $6.1 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
44,523
Previous 45,389 1.91%
Holding current value
$6.1 Million
Previous $6.22 Million 1.91%
% of portfolio
0.09%
Previous 0.1%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 04, 2025
SELL
N/A
-866 Reduced 1.91%
44,523 $6.1 Million
Q3 2024

Nov 05, 2024
SELL
$137.09 - $137.09 $402,084 - $402,084
-2,933 Reduced 6.07%
45,389 $6.22 Million
Q2 2024

Aug 07, 2024
SELL
$125.91 - $144.34 $25,056 - $28,723
-199 Reduced 0.41%
48,322 $6.61 Million
Q1 2024

May 06, 2024
SELL
$123.78 - $142.11 $167,474 - $192,274
-1,353 Reduced 2.71%
48,521 $6.46 Million
Q4 2023

Feb 13, 2024
BUY
$120.62 - $141.12 $3,980 - $4,656
33 Added 0.07%
49,874 $6.88 Million
Q3 2023

Nov 07, 2023
SELL
$121.86 - $144.92 $55,568 - $66,083
-456 Reduced 0.91%
49,841 $6.07 Million
Q2 2023

Aug 02, 2023
SELL
$130.56 - $146.84 $204,718 - $230,245
-1,568 Reduced 3.02%
50,297 $7.07 Million
Q1 2023

May 10, 2023
SELL
$131.53 - $155.76 $692,242 - $819,764
-5,263 Reduced 9.21%
51,865 $7.34 Million
Q4 2022

Feb 07, 2023
SELL
$123.31 - $157.26 $487,814 - $622,120
-3,956 Reduced 6.48%
57,128 $8.94 Million
Q3 2022

Nov 14, 2022
SELL
$121.77 - $141.1 $202,016 - $234,084
-1,659 Reduced 2.64%
61,084 $7.49 Million
Q2 2022

Aug 08, 2022
BUY
$127.07 - $145.39 $275,233 - $314,914
2,166 Added 3.58%
62,743 $8.34 Million
Q1 2022

May 12, 2022
BUY
$129.09 - $164.35 $489,509 - $623,215
3,792 Added 6.68%
60,577 $8.29 Million
Q4 2021

Feb 02, 2022
SELL
$140.36 - $173.01 $8,281 - $10,207
-59 Reduced 0.1%
56,785 $9.82 Million
Q3 2021

Nov 12, 2021
BUY
$132.95 - $158.0 $135,210 - $160,686
1,017 Added 1.82%
56,844 $8.26 Million
Q2 2021

Aug 03, 2021
SELL
$126.66 - $141.48 $47,624 - $53,196
-376 Reduced 0.67%
55,827 $7.37 Million
Q1 2021

May 10, 2021
BUY
$114.63 - $133.34 $6,304 - $7,333
55 Added 0.1%
56,203 $7.21 Million
Q4 2020

Feb 11, 2021
SELL
$112.7 - $128.05 $25,582 - $29,067
-227 Reduced 0.4%
56,148 $6.69 Million
Q3 2020

Nov 13, 2020
SELL
$107.05 - $130.01 $16,378 - $19,891
-153 Reduced 0.27%
56,375 $6.46 Million
Q2 2020

Aug 11, 2020
SELL
$73.34 - $122.61 $15,181 - $25,380
-207 Reduced 0.36%
56,528 $6.44 Million
Q1 2020

May 08, 2020
BUY
$75.14 - $115.68 $37,870 - $58,302
504 Added 0.9%
56,735 $4.56 Million
Q4 2019

Feb 07, 2020
BUY
$100.29 - $107.99 $118,542 - $127,644
1,182 Added 2.15%
56,231 $6.01 Million
Q3 2019

Oct 31, 2019
BUY
$97.85 - $107.42 $46,772 - $51,346
478 Added 0.88%
55,049 $5.89 Million
Q2 2019

Aug 09, 2019
SELL
$85.18 - $101.94 $56,218 - $67,280
-660 Reduced 1.19%
54,571 $5.56 Million
Q1 2019

Apr 24, 2019
BUY
$80.68 - $89.92 $76,242 - $84,974
945 Added 1.74%
55,231 $4.97 Million
Q4 2018

Jan 29, 2019
BUY
$79.75 - $108.38 $130,630 - $177,526
1,638 Added 3.11%
54,286 $4.52 Million
Q3 2018

Oct 26, 2018
SELL
$105.42 - $114.99 $46,701 - $50,940
-443 Reduced 0.83%
52,648 $5.68 Million
Q2 2018

Aug 10, 2018
SELL
$97.35 - $113.14 $622,747 - $723,756
-6,397 Reduced 10.75%
53,091 $5.84 Million
Q1 2018

May 01, 2018
SELL
$96.42 - $107.88 $8,870 - $9,924
-92 Reduced 0.15%
59,488 $5.97 Million
Q4 2017

Feb 07, 2018
BUY
$90.86 - $100.24 $64,328 - $70,969
708 Added 1.2%
59,580 $5.87 Million
Q3 2017

Nov 09, 2017
BUY
$91.96 - $108.35 $5.41 Million - $6.38 Million
58,872
58,872 $5.51 Million

Others Institutions Holding DGX

# of Institutions
984
Shares Held
98.6M
Call Options Held
417K
Put Options Held
227K
View Full List

About QUEST DIAGNOSTICS INC

DGX Quotes by TradingView
  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Oppenheimer & CO Inc Portfolio

Follow Oppenheimer & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email